Persistent Psychosis After a Single Ingestion of "Ecstasy" (MDMA).
作者信息
Patel Ankit, Moreland Toby, Haq Fasiha, Siddiqui Fatima, Mikul Melissa, Qadir Huma, Raza Shakeel
机构信息
Department of Psychiatry, University of South Alabama, Mobile.
出版信息
Prim Care Companion CNS Disord. 2011;13(6). doi: 10.4088/PCC.11l01200.
Abstract
摘要
相似文献
1
Persistent Psychosis After a Single Ingestion of "Ecstasy" (MDMA).单次摄入“摇头丸”（3,4－亚甲基二氧甲基苯丙胺）后出现的持续性精神病
Prim Care Companion CNS Disord. 2011;13(6). doi: 10.4088/PCC.11l01200.
2
3
[A case of acute psychotic episode after a single dose of ecstasy].[一例单次服用摇头丸后出现急性精神病发作的病例]
Encephale. 2001 Mar-Apr;27(2):198-202.
4
Persistent Psychosis due to Single Dose of Ecstasy.单次服用摇头丸所致的持续性精神病
Cureus. 2018 Jul 27;10(7):e3058. doi: 10.7759/cureus.3058.
5
Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK.英国“摇头丸”片剂中 3,4-亚甲二氧基甲基苯丙胺含量的变异性。
Emerg Med J. 2011 Sep;28(9):764-5. doi: 10.1136/emj.2010.092270. Epub 2010 Aug 19.
6
Panic disorder due to ingestion of single dose ecstasy.因单次摄入摇头丸导致惊恐障碍。
Int J Psychiatry Clin Pract. 2005;9(2):138-41. doi: 10.1080/13651500510028968.
7
The Detection of Novel Stimulants in Oral Fluid from Users Reporting Ecstasy, Molly and MDMA Ingestion.报告服用摇头丸、莫莉和MDMA的使用者口腔液中新型兴奋剂的检测。
J Anal Toxicol. 2018 Oct 1;42(8):544-553. doi: 10.1093/jat/bky051.
8
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.当前和曾经使用摇头丸（MDMA）者的情绪、认知与血清素转运体可用性：纵向研究视角
J Psychopharmacol. 2006 Mar;20(2):211-25. doi: 10.1177/0269881106059486.
9
Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?亚甲二氧基苯丙胺（摇头丸）对人体的神经毒性：持续性脑损伤的证据有多确凿？
Addiction. 2006 Mar;101(3):348-61. doi: 10.1111/j.1360-0443.2006.01314.x.
10
Multiple drug ingestion by ecstasy abusers in the United States.美国摇头丸滥用者的多种药物摄入情况。
J Anal Toxicol. 2009 Apr;33(3):143-7. doi: 10.1093/jat/33.3.143.
引用本文的文献
1
Navigating Treatment Challenges: A Case Study on Refractory Psychosis in a Chronic MDMA (3,4-Methylenedioxymethamphetamine) User.应对治疗挑战：一名慢性摇头丸（3,4-亚甲基二氧甲基苯丙胺）使用者难治性精神病的案例研究
Cureus. 2024 May 4;16(5):e59641. doi: 10.7759/cureus.59641. eCollection 2024 May.
2
Brain dysfunctions and neurotoxicity induced by psychostimulants in experimental models and humans: an overview of recent findings.精神兴奋剂在实验模型和人类中引起的脑功能障碍和神经毒性：近期研究结果综述
Neural Regen Res. 2024 Sep 1;19(9):1908-1918. doi: 10.4103/1673-5374.390971. Epub 2023 Dec 15.
3
MDMA for the Treatment of Negative Symptoms in Schizophrenia.摇头丸用于治疗精神分裂症的阴性症状。
J Clin Med. 2022 Jun 7;11(12):3255. doi: 10.3390/jcm11123255.
4
Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use.长期使用大麻和摇头丸的青少年中的轻度精神病症状
Front Psychiatry. 2022 Jan 21;12:696133. doi: 10.3389/fpsyt.2021.696133. eCollection 2021.
5
MDMA Abuse in Relation to MicroRNA Variation in Human Brain Ventral Tegmental Area and Nucleus Accumbens.摇头丸滥用与人类脑腹侧被盖区和伏隔核中微小RNA变异的关系。
Iran J Pharm Res. 2019 Fall;18(4):1989-1999. doi: 10.22037/ijpr.2019.15097.12874.
6
Comparative psychopharmacology of autism and psychotic-affective disorders suggests new targets for treatment.自闭症与精神情感障碍的比较心理药理学研究为治疗提供了新靶点。
Evol Med Public Health. 2019 Aug 26;2019(1):149-168. doi: 10.1093/emph/eoz022. eCollection 2019.
7
Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia.氯胺酮所致精神病与精神分裂症的阳性和阴性症状量表初步分析
J Psychiatr Res. 2015 Feb;61:64-72. doi: 10.1016/j.jpsychires.2014.12.012. Epub 2014 Dec 24.
8
Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.甲基苯丙胺和 3,4-亚甲二氧基甲基苯丙胺的神经毒性。
Life Sci. 2014 Feb 27;97(1):37-44. doi: 10.1016/j.lfs.2013.07.014. Epub 2013 Jul 24.
本文引用的文献
1
2
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.当前和曾经使用摇头丸（MDMA）者的情绪、认知与血清素转运体可用性：纵向研究视角
J Psychopharmacol. 2006 Mar;20(2):211-25. doi: 10.1177/0269881106059486.
3
Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?亚甲二氧基苯丙胺（摇头丸）对人体的神经毒性：持续性脑损伤的证据有多确凿？
Addiction. 2006 Mar;101(3):348-61. doi: 10.1111/j.1360-0443.2006.01314.x.
4
Neuropsychiatric consequences (atypical psychosis and complex-partial seizures) of ecstasy use: possible evidence for toxicity-vulnerability predictors and implications for preventative and clinical care.摇头丸使用的神经精神后果（非典型精神病和复杂部分性发作）：毒性易感性预测指标的可能证据及其对预防和临床护理的意义。
J Psychopharmacol. 2003 Sep;17(3):342-5. doi: 10.1177/02698811030173018.
5
Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate.俱乐部药物：亚甲二氧基甲基苯丙胺、氟硝西泮、氯胺酮盐酸盐和γ-羟基丁酸。
Am J Health Syst Pharm. 2002 Jun 1;59(11):1067-76. doi: 10.1093/ajhp/59.11.1067.
6
Ecstasy in the brain: a model for neuroimaging.大脑中的摇头丸：一种神经成像模型。
J Neuropsychiatry Clin Neurosci. 2002 Spring;14(2):125-9. doi: 10.1176/jnp.14.2.125.
7
Persistent psychosis after a single ingestion of 'ecstasy'.单次服用摇头丸后出现的持续性精神病症状。
Psychosomatics. 2001 Nov-Dec;42(6):525-7. doi: 10.1176/appi.psy.42.6.525.
8
Ecstasy (MDMA): a review of its possible persistent psychological effects.摇头丸（3,4－亚甲基二氧甲基苯丙胺）：对其可能存在的持续性心理影响的综述
Psychopharmacology (Berl). 2000 Oct;152(3):230-48. doi: 10.1007/s002130000545.
9
Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA: "Ecstasy").使用3,4-亚甲基二氧甲基苯丙胺（摇头丸：“迷幻药”）后的神经精神表现。
Prog Neuropsychopharmacol Biol Psychiatry. 1997 May;21(4):727-34. doi: 10.1016/s0278-5846(97)00045-6.
10
M.D.M.A. ("Ecstasy"); a case of possible drug-induced psychosis.摇头丸（“狂喜”）；一例可能由药物引起的精神病病例。
Ir J Med Sci. 1993 Feb;162(2):43-4. doi: 10.1007/BF02942900.
Zotero 插件